The second batch of offpatent drugs published by China CDE
The second batch of off patent drugs published by China Center for Drug Evaluation (CDE) contains 7 abroad approved drugs, which are regarded as clinically valued and the patent of chemical compounds has been expired, invalid or terminated in China, however, there is still no generic drug application in China until October, 2018. The Anti-HIV…